Tumour escape from immune surveillance through dendritic cell inactivation - PubMed (original) (raw)
Review
Tumour escape from immune surveillance through dendritic cell inactivation
Alain P Vicari et al. Semin Cancer Biol. 2002 Feb.
Abstract
Dendritic cells (DC) are central to the initiation of immunity. To induce immune reactivity, DC are recruited at the site of antigen expression, uptake antigens and migrate to secondary lymphoid organs while receiving activation signals delivered by pathogens, dying cells, and/or T cells. Tumours can escape the immune system by interfering with the migration of DC or by not providing the necessary activation signals. Moreover, tumours promote the secretion of factors that inhibit DC differentiation and functions. We will review the current knowledge of the physiopathology of DC in cancer, which paves the way for novel strategies of therapeutic intervention.
Similar articles
- Tumor-host immune interactions and dendritic cell dysfunction.
Yang L, Carbone DP. Yang L, et al. Adv Cancer Res. 2004;92:13-27. doi: 10.1016/S0065-230X(04)92002-7. Adv Cancer Res. 2004. PMID: 15530555 Review. - Immune regulation by dendritic cells and T cells--basic science, diagnostic, and clinical application.
Tuettenberg A, Becker C, Correll A, Steinbrink K, Jonuleit H. Tuettenberg A, et al. Clin Lab. 2011;57(1-2):1-12. Clin Lab. 2011. PMID: 21391459 Review. - Dendritic cells from bench to bedside and back.
Adema GJ. Adema GJ. Immunol Lett. 2009 Feb 21;122(2):128-30. doi: 10.1016/j.imlet.2008.11.017. Epub 2008 Dec 31. Immunol Lett. 2009. PMID: 19121337 Review. - Myeloid dendritic cell: From sentinel of immunity to key player of peripheral tolerance?
Steinbrink K, Mahnke K, Grabbe S, Enk AH, Jonuleit H. Steinbrink K, et al. Hum Immunol. 2009 May;70(5):289-93. doi: 10.1016/j.humimm.2009.02.003. Epub 2009 Feb 13. Hum Immunol. 2009. PMID: 19217922 Review. - The dendritic cell system and anti-tumour immunity.
Austyn JM. Austyn JM. In Vivo. 1993 May-Jun;7(3):193-201. In Vivo. 1993. PMID: 8357961 Review.
Cited by
- Galectin-8 alters immune microenvironment and promotes tumor progression.
Wang Y, Sun Y, Li H, Xu J. Wang Y, et al. Am J Cancer Res. 2023 Jun 15;13(6):2517-2529. eCollection 2023. Am J Cancer Res. 2023. PMID: 37424827 Free PMC article. - The M2 macrophages infiltration of sebaceous tumors is linked to the aggressiveness of tumors but not to the mismatch repair pathway.
Frouin E, Alleyrat C, Godet J, Karayan-Tapon L, Sinson H, Morel F, Lecron JC, Favot L. Frouin E, et al. J Cancer Res Clin Oncol. 2023 Aug;149(9):6445-6454. doi: 10.1007/s00432-023-04629-x. Epub 2023 Feb 10. J Cancer Res Clin Oncol. 2023. PMID: 36763173 - The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited.
Dzobo K, Senthebane DA, Dandara C. Dzobo K, et al. Cancers (Basel). 2023 Jan 6;15(2):376. doi: 10.3390/cancers15020376. Cancers (Basel). 2023. PMID: 36672326 Free PMC article. Review. - Beyond direct killing-novel cellular immunotherapeutic strategies to reshape the tumor microenvironment.
Huynh D, Winter P, Märkl F, Endres S, Kobold S. Huynh D, et al. Semin Immunopathol. 2023 Mar;45(2):215-227. doi: 10.1007/s00281-022-00962-4. Epub 2022 Sep 27. Semin Immunopathol. 2023. PMID: 36167831 Free PMC article. Review. - Friends with Benefits: Chemokines, Glioblastoma-Associated Microglia/Macrophages, and Tumor Microenvironment.
Codrici E, Popescu ID, Tanase C, Enciu AM. Codrici E, et al. Int J Mol Sci. 2022 Feb 24;23(5):2509. doi: 10.3390/ijms23052509. Int J Mol Sci. 2022. PMID: 35269652 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources